Improved long-term outcomes after renal transplantation associated with blood pressure control

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2725-2731

  Opelz, Gerhard ^a   Döhler, Bernd ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Blood pressure control; Hypertension; Long term transplant outcomes; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CADAVER KIDNEY; CARDIOVASCULAR DISEASE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DATA BASE; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD; BLOOD PRESSURE; FOLLOW UP; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; TIME;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CREATININE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644796696     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01093.x     Document Type: Article

References (21)

1. Hariharan S. Long-term kidney transplant survival. Am J Kidney Dis 2001 38 ( Suppl 6 S44 S50.
2. Klag MJ Whelton PK Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996 334: 13 18.
3. Chobanian AV Bakris GL Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42: 1206 1252.
4. Whitworth JA. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003 21: 1983 1992.
5. Lewington S Clarke R Qizilbash N Peto R Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 360: 1903 1913.
6. Opelz G Wujciak T Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998 53: 217 222.
7. Mange KC Cizman B Joffe M Feldman HL. Arterial hypertension and renal allograft survival. JAMA 2000 283: 633 638.
8. Kasiske BL Anjum S Shah R et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004 43: 1071 1081.
9. Walker WG Neaton JD Cutler JA Neuwirth R Cohen JD. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 1992 268: 3085 3091.
10. Peterson JC Adler S Burkart JM et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995 123: 754 762.
11. Mourad G Ribstein J Mimran A. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 1993 43: 419 425.
12. Collaborative Transplant Study. http://www.ctstransplant.org. Accessed March 1, 2005.
13. Raine AEG. Does antihypertensive therapy modify chronic allograft failure¿ Kidney Int 1995 48 ( Suppl 52 S107 S111.
14. Ojo AO Hanson JA Wolfe RA Leichtman AB Agodoa LY Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000 57: 307 313.
15. Kasiske BL. Cardiovascular disease after renal transplantation. Semin Nephrol 2000 20: 176 187.
16. Sanders CE Curtis JJ. Role of hypertension in chronic renal allograft dysfunction. Kidney Int 1995 48 ( Suppl 52 S43 S47.
17. Curtis JJ. Distinguishing the causes of post-transplantation hypertension. Pediatr Nephrol 1991 5: 108 111.
18. Midtvedt K Hartmann A. Hypertension after kidney transplantation: Are treatment guidelines emerging¿ Nephrol Dial Transplant 2002 17: 1166 1169.
19. Zeier M Mandelbaum A Ritz E. Hypertension in the transplanted patient. Nephron 1998 80: 257 268.
20. Barnett AH Bain SC Bouter P et al. Diabetics Exposed to Telmisartan and Enalapril Study Group. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004 351 ( 19 1952 1961.
21. Coyle JD Gardner SF White CM. The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus. Ann Pharmacother 2004 38: 1731 1738.